Frank T. Watkins - Jun 16, 2021 Form 4 Insider Report for Shockwave Medical, Inc. (SWAV)

Role
Director
Signature
/s/ Wade Estey, as attorney-in-fact for Frank T. Watkins
Stock symbol
SWAV
Transactions as of
Jun 16, 2021
Transactions value $
-$385,294
Form type
4
Date filed
6/17/2021, 06:53 PM
Previous filing
Jun 16, 2021
Next filing
Jul 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Sale -$76.7K -403 -0.52% $190.20 76.5K Jun 16, 2021 Direct F1, F2
transaction SWAV Common Stock Sale -$56.2K -294 -0.38% $191.30 76.3K Jun 16, 2021 Direct F3
transaction SWAV Common Stock Sale -$29.6K -154 -0.2% $192.30 76.1K Jun 16, 2021 Direct F4
transaction SWAV Common Stock Sale -$118K -610 -0.8% $193.35 75.5K Jun 16, 2021 Direct F5
transaction SWAV Common Stock Sale -$73.2K -377 -0.5% $194.25 75.1K Jun 16, 2021 Direct F6
transaction SWAV Common Stock Sale -$31.6K -162 -0.22% $195.13 75K Jun 16, 2021 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 16, 2020.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $189.76 to $190.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $190.77 to $191.76. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $191.77 to $192.68. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $192.83 to $193.82. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $193.83 to $194.78. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $194.83 to $195.73. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.